Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.JHP Pharmaceuticals has signed an agreement with an undisclosed pharmaceutical company to produce lyophilized biologic supplies for international, late-phase clinical trials.
Subscribe to our email newsletter
JHP president and CEO Stuart Hinchen said customers look at JHP’s established infrastructure to progress products from clinical to commercial supply.
”Additionally, our cGMP compliance record and experienced staff allows customers to focus on their pressing business needs with confidence," Hinchen added.
US-based JHP, which manufactures products for sale in 86 countries, has also supported launches of several products in US and international markets in the past.
JHP manufactures sterile products that include biologics, small molecule, controlled substances, vaccines, ophthalmics, otics and antibiotics for pharmaceutical and biotech organizations.